Abalonyx was founded in 2005 by Dr. Rune Wendelbo in collaboration with Oslo Innovation Center AS. Several major projects funded by the Reseach Council of Norway, Innovation Norway and EU have been completed, resulting in a portfolio of technologies and products now ready for commercialization. In 2014, Kongsberg Innovation AS became part owner of Abalonyx but sold its' shares to Neutrino Holding AS in early 2020. Neutrino Holding AS now owns 100 % of the company, and has so far in 2020 made two investments in Abalonyx, the new capital to be used to set up a new production line for graphene oxide to increase production capacity bey 300 % and to REACH-register for graphene oxide. Graphene oxide is Abalonyx' main product, and since 2014, a range of graphene oxide derivatives have been developed. Graphene oxide and graphene oxide derivatives are sold worldwide and Abalonyx is at present the only company selling Kg-amounts of graphene oxide in the open market.